Human pharmacokinetics and safety profile of finafloxacin, a new fluoroquinolone antibiotic, in healthy volunteers.
about
Chemical structure and pharmacokinetics of novel quinolone agents represented by avarofloxacin, delafloxacin, finafloxacin, zabofloxacin and nemonoxacinPharmacodynamics of Finafloxacin, Ciprofloxacin, and Levofloxacin in Serum and Urine against TEM- and SHV-Type Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae Isolates from Patients with Urinary Tract Infections.Demonstrating the Protective Efficacy of the Novel Fluoroquinolone Finafloxacin against an Inhalational Exposure to Burkholderia pseudomallei.Renaissance of antibiotics against difficult infections: Focus on oritavancin and new ketolides and quinolones.Finafloxacin: first global approval.Finafloxacin for the treatment of urinary tract infections.Pharmacokinetics of intravenous finafloxacin in healthy volunteers.The antibiotic pipeline for multi-drug resistant gram negative bacteria: what can we expect?What we may expect from novel antibacterial agents in the pipeline with respect to resistance and pharmacodynamic principles.Population pharmacokinetics of finafloxacin in healthy volunteers and patients with complicated urinary tract infections.Efficacy and Safety of Finafloxacin versus Ciprofloxacin in the Treatment of Complicated Urinary Tract Infections: An Explorative Randomized Phase II Clinical Study.
P2860
Q26746616-B1202E75-B19D-4C0B-81EB-9F8B9EFC69E8Q33601794-565058F9-2B15-4599-8D05-F01E23D448F6Q33843665-677FB6A8-566B-4EB7-A717-223B300FE5E9Q38233471-7EAB893B-FAE1-4EC1-989F-7B0D3CE2EF84Q38391019-853613CC-BF7D-4D33-9679-FD949201B4D7Q38526001-4C93A724-59EA-48BE-85A0-52B16A9DBE4EQ38636236-E8BE8D48-3A95-40AD-B3BF-1B6D2A86CBF9Q38892589-4C83D82B-A2B0-4555-9395-CA74421D5C40Q39120027-62C98A8E-C738-482D-AD86-13579833B9ECQ48232629-75761E6B-E855-4BAA-BF2D-6678CF8B751FQ50020710-9A73341E-8D5B-4B57-AEA4-D8549D45932E
P2860
Human pharmacokinetics and safety profile of finafloxacin, a new fluoroquinolone antibiotic, in healthy volunteers.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Human pharmacokinetics and saf ...... biotic, in healthy volunteers.
@ast
Human pharmacokinetics and saf ...... biotic, in healthy volunteers.
@en
type
label
Human pharmacokinetics and saf ...... biotic, in healthy volunteers.
@ast
Human pharmacokinetics and saf ...... biotic, in healthy volunteers.
@en
prefLabel
Human pharmacokinetics and saf ...... biotic, in healthy volunteers.
@ast
Human pharmacokinetics and saf ...... biotic, in healthy volunteers.
@en
P2093
P2860
P356
P1476
Human pharmacokinetics and saf ...... ibiotic, in healthy volunteers
@en
P2093
Andreas Vente
Arne Andresen
Hans-Dietrich Heilmann
Harald Labischinski
Heena Patel
Michael Seiberling
Rolf Pokorny
Will Stubbings
P2860
P304
P356
10.1128/AAC.00832-10
P407
P577
2011-06-27T00:00:00Z